Metabolite

KNApSAcK Entry

id C00009384
Name 3'-Hydroxydaidzein / 7,3',4'-Trihydroxyisoflavone
CAS RN 485-63-2
Standard InChI InChI=1S/C15H10O5/c16-9-2-3-10-14(6-9)20-7-11(15(10)19)8-1-4-12(17)13(18)5-8/h1-7,16-18H
Standard InChI (Main Layer) InChI=1S/C15H10O5/c16-9-2-3-10-14(6-9)20-7-11(15(10)19)8-1-4-12(17)13(18)5-8/h1-7,16-18H

Cluster

Phytochemical cluster No. 15
KCF-S cluster No. 71

Link

ChEMBL

By standard InChI CHEMBL13486
By standard InChI Main Layer CHEMBL13486

KEGG

By LinkDB C14313

CTD

By CAS RN C061213

Human Protein / Gene in interaction

4 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P47989 Xanthine dehydrogenase/oxidase Oxidoreductase CHEMBL13486 CHEMBL991725 (1) CHEMBL990777 (1)
1 / 1
P11388 DNA topoisomerase 2-alpha Isomerase CHEMBL13486 CHEMBL1014691 (1)
0 / 0
P14174 Macrophage migration inhibitory factor Enzyme CHEMBL13486 CHEMBL711481 (1) CHEMBL1021636 (1)
1 / 0
P37231 Peroxisome proliferator-activated receptor gamma NR1C3 CHEMBL13486 CHEMBL1059360 (1) CHEMBL1059361 (1)
5 / 3

CTD interaction (34)

compound gene gene name gene description interaction interaction type form reference
pmid
C061213 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) 3',4',7-trihydroxyisoflavone inhibits the reaction [Epirubicin results in increased expression of ABCB1 mRNA] decreases reaction
/ increases expression
mRNA 22914566
C061213 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) 3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA decreases expression
mRNA 22914566
C061213 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) Ascorbic Acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 3',4',7-trihydroxyisoflavone inhibits the reaction [Epirubicin results in increased expression of ABCC1 mRNA] decreases reaction
/ increases expression
mRNA 22914566
C061213 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA decreases expression
mRNA 22914566
C061213 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 Ascorbic Acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 3',4',7-trihydroxyisoflavone inhibits the reaction [Epirubicin results in increased expression of ABCC2 mRNA] decreases reaction
/ increases expression
mRNA 22914566
C061213 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA decreases expression
mRNA 22914566
C061213 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 Ascorbic Acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA] decreases expression
/ decreases reaction
mRNA 22914566
C061213 581 BAX
BCL2L4
BCL2-associated X protein 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of BAX mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 581 BAX
BCL2L4
BCL2-associated X protein 3',4',7-trihydroxyisoflavone results in increased expression of BAX mRNA increases expression
mRNA 22914566
C061213 581 BAX
BCL2L4
BCL2-associated X protein Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of BAX mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP3 mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) 3',4',7-trihydroxyisoflavone results in increased activity of CASP3 protein increases activity
protein 22914566
C061213 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) 3',4',7-trihydroxyisoflavone results in increased expression of CASP3 mRNA increases expression
mRNA 22914566
C061213 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 22914566
C061213 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of CASP3 mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) 3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein increases activity
protein 22914566
C061213 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) 3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA increases expression
mRNA 22914566
C061213 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein] increases activity
/ increases reaction
protein 22914566
C061213 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA] decreases expression
/ decreases reaction
protein 22914566
C061213 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA] decreases expression
/ decreases reaction
protein 22914566
C061213 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA] decreases expression
/ decreases reaction
protein 22914566
C061213 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of TP53 mRNA] increases expression
/ increases reaction
mRNA 22914566
C061213 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 3',4',7-trihydroxyisoflavone results in increased expression of TP53 mRNA increases expression
mRNA 22914566
C061213 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of TP53 mRNA] increases expression
/ increases reaction
mRNA 22914566

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (7)

OMIM preferred title UniProt
%606641 Body mass index; bmi P37231
#609338 Carotid intimal medial thickness 1 P37231
#137800 Glioma susceptibility 1; glm1 P37231
#604367 Lipodystrophy, familial partial, type 3; fpld3 P37231
#601665 Obesity P37231
#604302 Rheumatoid arthritis, systemic juvenile P14174
#278300 Xanthinuria, type i P47989

KEGG DISEASE (4)

KEGG disease name UniProt
H00032 Thyroid cancer P37231 (related)
H00409 Type II diabetes mellitus P37231 (related)
H00420 Familial partial lipodystrophy (FPL) P37231 (related)
H00192 Xanthinuria P47989 (related)